期刊文献+

经皮冠状动脉介入治疗术后对比剂肾病发病率及危险因素分析 被引量:18

The Incidence and Risk Factors for Contrast Induced Nephropathy after Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的:探讨经皮冠状动脉介入治疗(PCI)术后对比剂肾病(CIN)发病率及危险因素。方法:回顾性分析2008年1月—2010年12月行PCI术患者共1010例,根据CIN诊断标准将其分为CIN组171例(16.9%)和非CIN组839例,比较2组相关因素的差异,应用Logistic回归分析CIN危险因素。结果:2组年龄、血糖、血红蛋白、红细胞、红细胞比容、三酰甘油、胆固醇、高密度脂蛋白、低密度脂蛋白、收缩压、左室射血分数(LVEF)、白蛋白、肌酐清除率(Ccr)、榕血Ccr、对比剂用量差异有统计学意义(P<0.05或P<0.01)。Logistic回归分析显示,年龄≥70岁、心肌梗死、急诊PCI、糖尿病、低血压、贫血、Ccr≤60mL/min、对比剂用量>200mL、LVEF≤0.45是发生CIN的危险因素。结论:CIN是PCI术后常见并发症,对具备CIN危险因素的高危患者应引起临床上高度重视。 Objective: To investigate the incidence and risk factors for contrast induced nephropathy (CIN) after percuta neous coronary intervention (PCI). Methods: A retrospective study was performed on 1 010 patients who had undergone PCI from January 2008 to December 2010. According to the diagnostic criteria for CIN, the patients were divided into CIN group and non-CIN group. The related factors were compared between the two groups. Logistic regression analysis was applied to determine the risk factors for CIN. Results: There were significant differences in the patient age and values of blood glucose hemoglobin, red blood cells, hematocrit, triacylglyeerol, cholesterol, high density lipoprotein, low density lipoprotein, systolic blood pressure, left ventricular ejection fraction (LVEF), albumin, creatinine clearance (Ccr), and contrast agent volume between two groups (P 〈 0.05 or P 〈 0.01). Logistic regression analysis showed that age≥70 years, myocardial infarction, emergency PCI, diabetes mellitus, hypotension, anemia, Ccr≤60 mL/min, contrast agent volume〉200 mL and LVE≤0.45 were risk factors of CIN. Conclusion: CIN is a common complication after PCI. More attention should be paid to patients who have risk factors of CIN.
出处 《天津医药》 CAS 北大核心 2011年第10期903-906,共4页 Tianjin Medical Journal
基金 天津市卫生局级科技基金攻关课题(项目编号:10KG122)
关键词 血管成形术 经腔 经皮冠状动脉 肾病 危险因素 发病率 LOGISTIC模型 造影剂 angioplasty, transluminal, percutaneous coronary nephrosis risk factors incidence Logistic models contrast media
  • 相关文献

参考文献7

  • 1Toprak O. Risk markers for contrast induced nephropathy[J].Am J Med Sci, 2007,334(4):283-290.
  • 2Cho JY, Jeong MH, Hwan Park S,et al. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure[J]. J Cardiol,2010,56(3): 300-306.
  • 3Rosenstock JL, Gilles E, Geller AB,et al. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with- chronic kidney disease[J]. Int Urol Nephrol,2010,42(4):1049-1054.
  • 4Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction[J]. J Am Coll Cardiol, 2004,44(9):1780-1785.
  • 5Senoo T, Motohiro M, Kamihata H,et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome[J].Am J Cardiol, 2010, 105(5): 624-628.
  • 6Hernandez F, Mora L, Garcia-Tejada J,et al. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty[J].Rev Esp Cardiol, 2009, 62(12): 1373-1380.
  • 7Reed MC, Moscucci M, Smith DE,et al.The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) [J].J Invasive Cardiol,2010,22( 10):467-472.

同被引文献214

  • 1邹古明,颜红兵.造影剂肾病的诊断与治疗现状[J].中国介入心脏病学杂志,2005,13(3):194-196. 被引量:78
  • 2韩雅玲.冠心病介入治疗的发展现状及展望[J].解放军医学杂志,2006,31(6):505-507. 被引量:2
  • 3汪斌,刘志忠,张丰富.冠状动脉介入诊治中高敏C反应蛋白与造影剂肾病的相关性分析[J].中国医药,2007,2(8):457-459. 被引量:35
  • 4李法琪,司良毅.老年医学.北京:科学出版社,2002.217-218.
  • 5Rihal CS, Textor SC, Grill DE, et al. Incidence and prognosticimportance of acute renal failure after percutaneous coronaryintervention[J].Circulation, 2002, 105 (19):2259-2264.
  • 6Toprak 0. Risk markers for contrast induced nephropathy [J].Am JMed Sci, 2007,334(4):283-290.
  • 7Castini D, Lucreziotti S, Bosotti L,et al. Prevention of contrastinduced Nephropathy: a single center randomized study [J].ClinCardiol,2010, 33(3): E63-68.
  • 8Heyman SN, Rosen S,Khamaisi M,et al. Reactive oxygen speciesand the pathogenesis of radiocontrast -induced nephropathy [J].Invest Radiol,2010,45(4): 188-195.
  • 9Melfi R, Nusca A, Patti G, et al. Statins and their role inprepercutaneous coronary intervention [JJ.Cur Cardiol Rep,2010,32(12):295-351.
  • 10Patti G, Ricottini E, Nusca A,et al. Short -term, high -doseAtorvastatin pretreatment to prevent contrast-induced nephropathyin patients with acute coronary syndromes undergoing percutaneouscoronary intervention (from the ARMYDA-CIN [atorvastatin forreduction of myocardial damage during angioplasty -contrast -induced nephropathy] trial)[J].Am J Cardiol, 2011,108(1):1-7.

引证文献18

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部